FDA Approves First Generic Versions of Ambien (Zolpidem Tartrate) for the Treatment of Insomnia.

M2 Presswire, April, 2007

M2 PRESSWIRE-24 April 2007-US FDA: FDA Approves First Generic Versions of Ambien (Zolpidem Tartrate) for the Treatment of Insomnia(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:23042007 The U.S. Food and Drug Administration (FDA) today approved the first generic versions of Ambien (zolpidem tartrate) immediate-release tablets.

Zolpidem (ZOLE-pi-dem) tartrate is a sedative-hypnotic drug indicated for the short-term treatment of insomnia. "The FDA's Office of Generic Drugs ensures that generic drugs are safe and effective for the American public through a rigorous scientific and ...